Insulin releasing and alpha-glucosidase inhibitory activity of ethyl acetate fraction of Acorus calamus in vitro and in vivo
2010 · Journal of Ethnopharmacology · 114 citations
https://doi.org/10.1016/j.jep.2009.12.044
M
Meimei Si
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
393
Citations
9
h-index
9
i10-index
Meimei Si is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Diabetes Treatment and Management. The author has an h-index of 9, co-authored 19 publications.
ORCID: 0000-0001-6564-0058Papers by this author
worksSafety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial
2022 · Signal Transduction and Targeted Therapy · 34 citations
https://doi.org/10.1038/s41392-021-00841-8
Efficacy and safety of iruplinalkib (WX-0593) in ALK-positive crizotinib-resistant advanced non-small cell lung cancer patients: a single-arm, multicenter phase II study (INTELLECT)
2023 · BMC Medicine · 20 citations
https://doi.org/10.1186/s12916-023-02738-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat